HULME ALLISON 4
4 · SOPHIRIS BIO INC. · Filed Jan 3, 2019
Insider Transaction Report
Form 4
HULME ALLISON
Chief Operating Officer
Transactions
- Award
Common Stock (Right to Buy)
2018-12-31+245,000→ 245,000 totalExercise: $0.83From: 2019-12-21Exp: 2028-12-30→ Common Stock (245,000 underlying)
Footnotes (1)
- [F1]33% of the shares subject to the option shall vest on December 21, 2019. The remainder shall vest monthly thereafter over the next two years until fully vested on December 21, 2021.